Table of Contents

September-October 2021; Volume 18,Issue 5

A

  1. AMEMIYA, YUTAKA

    1. Delayed MRI Enhancement of Colorectal Cancer Liver Metastases Is Associated With Metastatic Mutational Profile
      ARUN SETH, YUTAKA AMEMIYA, HELEN CHEUNG, EUGENE HSIEH, CALVIN LAW and LAURENT MILOT
      Cancer Genomics & Proteomics September 2021, 18 (5) 627-635; DOI: https://doi.org/10.21873/cgp.20285

B

  1. BOUVET, MICHAEL

    1. Multikinase-Inhibitor Screening in Drug-resistant Osteosarcoma Patient-derived Orthotopic Xenograft Mouse Models Identifies the Clinical Potential of Regorafenib
      TAKASHI HIGUCHI, KENTARO IGARASHI, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, MICHAEL BOUVET, HIROYUKI TSUCHIYA and ROBERT M. HOFFMAN
      Cancer Genomics & Proteomics September 2021, 18 (5) 637-643; DOI: https://doi.org/10.21873/cgp.20286

C

  1. CHEUNG, HELEN

    1. Delayed MRI Enhancement of Colorectal Cancer Liver Metastases Is Associated With Metastatic Mutational Profile
      ARUN SETH, YUTAKA AMEMIYA, HELEN CHEUNG, EUGENE HSIEH, CALVIN LAW and LAURENT MILOT
      Cancer Genomics & Proteomics September 2021, 18 (5) 627-635; DOI: https://doi.org/10.21873/cgp.20285

  2. CHOI, SANGJOON

    1. Invasive Stratified Mucin-producing Carcinoma (ISMC) of the Uterine Cervix: Clinicopathological and Molecular Characteristics With Special Emphasis on the First Description of Consistent Programmed Death-ligand 1 (PD-L1) Over-expression
      SANGJOON CHOI, SO-WOON KIM and HYUN-SOO KIM
      Cancer Genomics & Proteomics September 2021, 18 (5) 685-698; DOI: https://doi.org/10.21873/cgp.20290

E

  1. EUN, YOUNG-GYU

    1. SOD2- and NRF2-associated Gene Signature to Predict Radioresistance in Head and Neck Cancer
      JOO KYUNG NOH, SEON RANG WOO, MIYONG YUN, MIN KYEONG LEE, MOONKYOO KONG, SOONKI MIN, SU IL KIM, YOUNG CHAN LEE, YOUNG-GYU EUN and SEONG-GYU KO
      Cancer Genomics & Proteomics September 2021, 18 (5) 675-684; DOI: https://doi.org/10.21873/cgp.20289

  2. EXARCHOS, THEMIS P.

    1. Machine Learning Approaches on High Throughput NGS Data to Unveil Mechanisms of Function in Biology and Disease
      VASILEIOS C. PEZOULAS, ORSALIA HAZAPIS, NEFELI LAGOPATI, THEMIS P. EXARCHOS, ANDREAS V. GOULES, ATHANASIOS G. TZIOUFAS, DIMITRIOS I. FOTIADIS, IOANNIS G. STRATIS, ATHANASIOS N. YANNACOPOULOS and VASSILIS G. GORGOULIS
      Cancer Genomics & Proteomics September 2021, 18 (5) 605-626; DOI: https://doi.org/10.21873/cgp.20284

F

  1. FOTIADIS, DIMITRIOS I.

    1. Machine Learning Approaches on High Throughput NGS Data to Unveil Mechanisms of Function in Biology and Disease
      VASILEIOS C. PEZOULAS, ORSALIA HAZAPIS, NEFELI LAGOPATI, THEMIS P. EXARCHOS, ANDREAS V. GOULES, ATHANASIOS G. TZIOUFAS, DIMITRIOS I. FOTIADIS, IOANNIS G. STRATIS, ATHANASIOS N. YANNACOPOULOS and VASSILIS G. GORGOULIS
      Cancer Genomics & Proteomics September 2021, 18 (5) 605-626; DOI: https://doi.org/10.21873/cgp.20284

G

  1. GORGOULIS, VASSILIS G.

    1. Machine Learning Approaches on High Throughput NGS Data to Unveil Mechanisms of Function in Biology and Disease
      VASILEIOS C. PEZOULAS, ORSALIA HAZAPIS, NEFELI LAGOPATI, THEMIS P. EXARCHOS, ANDREAS V. GOULES, ATHANASIOS G. TZIOUFAS, DIMITRIOS I. FOTIADIS, IOANNIS G. STRATIS, ATHANASIOS N. YANNACOPOULOS and VASSILIS G. GORGOULIS
      Cancer Genomics & Proteomics September 2021, 18 (5) 605-626; DOI: https://doi.org/10.21873/cgp.20284

  2. GOULES, ANDREAS V.

    1. Machine Learning Approaches on High Throughput NGS Data to Unveil Mechanisms of Function in Biology and Disease
      VASILEIOS C. PEZOULAS, ORSALIA HAZAPIS, NEFELI LAGOPATI, THEMIS P. EXARCHOS, ANDREAS V. GOULES, ATHANASIOS G. TZIOUFAS, DIMITRIOS I. FOTIADIS, IOANNIS G. STRATIS, ATHANASIOS N. YANNACOPOULOS and VASSILIS G. GORGOULIS
      Cancer Genomics & Proteomics September 2021, 18 (5) 605-626; DOI: https://doi.org/10.21873/cgp.20284

H

  1. HAYASHI, KATSUHIRO

    1. Multikinase-Inhibitor Screening in Drug-resistant Osteosarcoma Patient-derived Orthotopic Xenograft Mouse Models Identifies the Clinical Potential of Regorafenib
      TAKASHI HIGUCHI, KENTARO IGARASHI, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, MICHAEL BOUVET, HIROYUKI TSUCHIYA and ROBERT M. HOFFMAN
      Cancer Genomics & Proteomics September 2021, 18 (5) 637-643; DOI: https://doi.org/10.21873/cgp.20286

  2. HAZAPIS, ORSALIA

    1. Machine Learning Approaches on High Throughput NGS Data to Unveil Mechanisms of Function in Biology and Disease
      VASILEIOS C. PEZOULAS, ORSALIA HAZAPIS, NEFELI LAGOPATI, THEMIS P. EXARCHOS, ANDREAS V. GOULES, ATHANASIOS G. TZIOUFAS, DIMITRIOS I. FOTIADIS, IOANNIS G. STRATIS, ATHANASIOS N. YANNACOPOULOS and VASSILIS G. GORGOULIS
      Cancer Genomics & Proteomics September 2021, 18 (5) 605-626; DOI: https://doi.org/10.21873/cgp.20284

  3. HIGUCHI, TAKASHI

    1. Multikinase-Inhibitor Screening in Drug-resistant Osteosarcoma Patient-derived Orthotopic Xenograft Mouse Models Identifies the Clinical Potential of Regorafenib
      TAKASHI HIGUCHI, KENTARO IGARASHI, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, MICHAEL BOUVET, HIROYUKI TSUCHIYA and ROBERT M. HOFFMAN
      Cancer Genomics & Proteomics September 2021, 18 (5) 637-643; DOI: https://doi.org/10.21873/cgp.20286

  4. HOFFMAN, ROBERT M.

    1. Multikinase-Inhibitor Screening in Drug-resistant Osteosarcoma Patient-derived Orthotopic Xenograft Mouse Models Identifies the Clinical Potential of Regorafenib
      TAKASHI HIGUCHI, KENTARO IGARASHI, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, MICHAEL BOUVET, HIROYUKI TSUCHIYA and ROBERT M. HOFFMAN
      Cancer Genomics & Proteomics September 2021, 18 (5) 637-643; DOI: https://doi.org/10.21873/cgp.20286

  5. HSIEH, EUGENE

    1. Delayed MRI Enhancement of Colorectal Cancer Liver Metastases Is Associated With Metastatic Mutational Profile
      ARUN SETH, YUTAKA AMEMIYA, HELEN CHEUNG, EUGENE HSIEH, CALVIN LAW and LAURENT MILOT
      Cancer Genomics & Proteomics September 2021, 18 (5) 627-635; DOI: https://doi.org/10.21873/cgp.20285

I

  1. IGARASHI, KENTARO

    1. Multikinase-Inhibitor Screening in Drug-resistant Osteosarcoma Patient-derived Orthotopic Xenograft Mouse Models Identifies the Clinical Potential of Regorafenib
      TAKASHI HIGUCHI, KENTARO IGARASHI, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, MICHAEL BOUVET, HIROYUKI TSUCHIYA and ROBERT M. HOFFMAN
      Cancer Genomics & Proteomics September 2021, 18 (5) 637-643; DOI: https://doi.org/10.21873/cgp.20286

K

  1. KASAHARA, KAZUO

    1. Paclitaxel Impedes EGFR-mutated PC9 Cell Growth via Reactive Oxygen Species-mediated DNA Damage and EGFR/PI3K/AKT/mTOR Signaling Pathway Suppression
      MD MOHIUDDIN and KAZUO KASAHARA
      Cancer Genomics & Proteomics September 2021, 18 (5) 645-659; DOI: https://doi.org/10.21873/cgp.20287
    2. The Mechanisms of the Growth Inhibitory Effects of Paclitaxel on Gefitinib-resistant Non-small Cell Lung Cancer Cells
      MD MOHIUDDIN and KAZUO KASAHARA
      Cancer Genomics & Proteomics September 2021, 18 (5) 661-673; DOI: https://doi.org/10.21873/cgp.20288

  2. KIM, HYUN-SOO

    1. Invasive Stratified Mucin-producing Carcinoma (ISMC) of the Uterine Cervix: Clinicopathological and Molecular Characteristics With Special Emphasis on the First Description of Consistent Programmed Death-ligand 1 (PD-L1) Over-expression
      SANGJOON CHOI, SO-WOON KIM and HYUN-SOO KIM
      Cancer Genomics & Proteomics September 2021, 18 (5) 685-698; DOI: https://doi.org/10.21873/cgp.20290

  3. KIM, SO-WOON

    1. Invasive Stratified Mucin-producing Carcinoma (ISMC) of the Uterine Cervix: Clinicopathological and Molecular Characteristics With Special Emphasis on the First Description of Consistent Programmed Death-ligand 1 (PD-L1) Over-expression
      SANGJOON CHOI, SO-WOON KIM and HYUN-SOO KIM
      Cancer Genomics & Proteomics September 2021, 18 (5) 685-698; DOI: https://doi.org/10.21873/cgp.20290

  4. KIM, SU IL

    1. SOD2- and NRF2-associated Gene Signature to Predict Radioresistance in Head and Neck Cancer
      JOO KYUNG NOH, SEON RANG WOO, MIYONG YUN, MIN KYEONG LEE, MOONKYOO KONG, SOONKI MIN, SU IL KIM, YOUNG CHAN LEE, YOUNG-GYU EUN and SEONG-GYU KO
      Cancer Genomics & Proteomics September 2021, 18 (5) 675-684; DOI: https://doi.org/10.21873/cgp.20289

  5. KIMURA, HIROAKI

    1. Multikinase-Inhibitor Screening in Drug-resistant Osteosarcoma Patient-derived Orthotopic Xenograft Mouse Models Identifies the Clinical Potential of Regorafenib
      TAKASHI HIGUCHI, KENTARO IGARASHI, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, MICHAEL BOUVET, HIROYUKI TSUCHIYA and ROBERT M. HOFFMAN
      Cancer Genomics & Proteomics September 2021, 18 (5) 637-643; DOI: https://doi.org/10.21873/cgp.20286

  6. KO, SEONG-GYU

    1. SOD2- and NRF2-associated Gene Signature to Predict Radioresistance in Head and Neck Cancer
      JOO KYUNG NOH, SEON RANG WOO, MIYONG YUN, MIN KYEONG LEE, MOONKYOO KONG, SOONKI MIN, SU IL KIM, YOUNG CHAN LEE, YOUNG-GYU EUN and SEONG-GYU KO
      Cancer Genomics & Proteomics September 2021, 18 (5) 675-684; DOI: https://doi.org/10.21873/cgp.20289

  7. KONG, MOONKYOO

    1. SOD2- and NRF2-associated Gene Signature to Predict Radioresistance in Head and Neck Cancer
      JOO KYUNG NOH, SEON RANG WOO, MIYONG YUN, MIN KYEONG LEE, MOONKYOO KONG, SOONKI MIN, SU IL KIM, YOUNG CHAN LEE, YOUNG-GYU EUN and SEONG-GYU KO
      Cancer Genomics & Proteomics September 2021, 18 (5) 675-684; DOI: https://doi.org/10.21873/cgp.20289

L

  1. LAGOPATI, NEFELI

    1. Machine Learning Approaches on High Throughput NGS Data to Unveil Mechanisms of Function in Biology and Disease
      VASILEIOS C. PEZOULAS, ORSALIA HAZAPIS, NEFELI LAGOPATI, THEMIS P. EXARCHOS, ANDREAS V. GOULES, ATHANASIOS G. TZIOUFAS, DIMITRIOS I. FOTIADIS, IOANNIS G. STRATIS, ATHANASIOS N. YANNACOPOULOS and VASSILIS G. GORGOULIS
      Cancer Genomics & Proteomics September 2021, 18 (5) 605-626; DOI: https://doi.org/10.21873/cgp.20284

  2. LAW, CALVIN

    1. Delayed MRI Enhancement of Colorectal Cancer Liver Metastases Is Associated With Metastatic Mutational Profile
      ARUN SETH, YUTAKA AMEMIYA, HELEN CHEUNG, EUGENE HSIEH, CALVIN LAW and LAURENT MILOT
      Cancer Genomics & Proteomics September 2021, 18 (5) 627-635; DOI: https://doi.org/10.21873/cgp.20285

  3. LEE, MIN KYEONG

    1. SOD2- and NRF2-associated Gene Signature to Predict Radioresistance in Head and Neck Cancer
      JOO KYUNG NOH, SEON RANG WOO, MIYONG YUN, MIN KYEONG LEE, MOONKYOO KONG, SOONKI MIN, SU IL KIM, YOUNG CHAN LEE, YOUNG-GYU EUN and SEONG-GYU KO
      Cancer Genomics & Proteomics September 2021, 18 (5) 675-684; DOI: https://doi.org/10.21873/cgp.20289

  4. LEE, YOUNG CHAN

    1. SOD2- and NRF2-associated Gene Signature to Predict Radioresistance in Head and Neck Cancer
      JOO KYUNG NOH, SEON RANG WOO, MIYONG YUN, MIN KYEONG LEE, MOONKYOO KONG, SOONKI MIN, SU IL KIM, YOUNG CHAN LEE, YOUNG-GYU EUN and SEONG-GYU KO
      Cancer Genomics & Proteomics September 2021, 18 (5) 675-684; DOI: https://doi.org/10.21873/cgp.20289

M

  1. MILOT, LAURENT

    1. Delayed MRI Enhancement of Colorectal Cancer Liver Metastases Is Associated With Metastatic Mutational Profile
      ARUN SETH, YUTAKA AMEMIYA, HELEN CHEUNG, EUGENE HSIEH, CALVIN LAW and LAURENT MILOT
      Cancer Genomics & Proteomics September 2021, 18 (5) 627-635; DOI: https://doi.org/10.21873/cgp.20285

  2. MIN, SOONKI

    1. SOD2- and NRF2-associated Gene Signature to Predict Radioresistance in Head and Neck Cancer
      JOO KYUNG NOH, SEON RANG WOO, MIYONG YUN, MIN KYEONG LEE, MOONKYOO KONG, SOONKI MIN, SU IL KIM, YOUNG CHAN LEE, YOUNG-GYU EUN and SEONG-GYU KO
      Cancer Genomics & Proteomics September 2021, 18 (5) 675-684; DOI: https://doi.org/10.21873/cgp.20289

  3. MIWA, SHINJI

    1. Multikinase-Inhibitor Screening in Drug-resistant Osteosarcoma Patient-derived Orthotopic Xenograft Mouse Models Identifies the Clinical Potential of Regorafenib
      TAKASHI HIGUCHI, KENTARO IGARASHI, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, MICHAEL BOUVET, HIROYUKI TSUCHIYA and ROBERT M. HOFFMAN
      Cancer Genomics & Proteomics September 2021, 18 (5) 637-643; DOI: https://doi.org/10.21873/cgp.20286

  4. MOHIUDDIN, MD

    1. Paclitaxel Impedes EGFR-mutated PC9 Cell Growth via Reactive Oxygen Species-mediated DNA Damage and EGFR/PI3K/AKT/mTOR Signaling Pathway Suppression
      MD MOHIUDDIN and KAZUO KASAHARA
      Cancer Genomics & Proteomics September 2021, 18 (5) 645-659; DOI: https://doi.org/10.21873/cgp.20287
    2. The Mechanisms of the Growth Inhibitory Effects of Paclitaxel on Gefitinib-resistant Non-small Cell Lung Cancer Cells
      MD MOHIUDDIN and KAZUO KASAHARA
      Cancer Genomics & Proteomics September 2021, 18 (5) 661-673; DOI: https://doi.org/10.21873/cgp.20288

N

  1. NOH, JOO KYUNG

    1. SOD2- and NRF2-associated Gene Signature to Predict Radioresistance in Head and Neck Cancer
      JOO KYUNG NOH, SEON RANG WOO, MIYONG YUN, MIN KYEONG LEE, MOONKYOO KONG, SOONKI MIN, SU IL KIM, YOUNG CHAN LEE, YOUNG-GYU EUN and SEONG-GYU KO
      Cancer Genomics & Proteomics September 2021, 18 (5) 675-684; DOI: https://doi.org/10.21873/cgp.20289

  2. NOPORA, ADAM

    1. MicroRNAs Involved in Small-cell Lung Cancer as Possible Agents for Treatment and Identification of New Targets
      ULRICH H. WEIDLE and ADAM NOPORA
      Cancer Genomics & Proteomics September 2021, 18 (5) 591-603; DOI: https://doi.org/10.21873/cgp.20283

P

  1. PEZOULAS, VASILEIOS C.

    1. Machine Learning Approaches on High Throughput NGS Data to Unveil Mechanisms of Function in Biology and Disease
      VASILEIOS C. PEZOULAS, ORSALIA HAZAPIS, NEFELI LAGOPATI, THEMIS P. EXARCHOS, ANDREAS V. GOULES, ATHANASIOS G. TZIOUFAS, DIMITRIOS I. FOTIADIS, IOANNIS G. STRATIS, ATHANASIOS N. YANNACOPOULOS and VASSILIS G. GORGOULIS
      Cancer Genomics & Proteomics September 2021, 18 (5) 605-626; DOI: https://doi.org/10.21873/cgp.20284

S

  1. SETH, ARUN

    1. Delayed MRI Enhancement of Colorectal Cancer Liver Metastases Is Associated With Metastatic Mutational Profile
      ARUN SETH, YUTAKA AMEMIYA, HELEN CHEUNG, EUGENE HSIEH, CALVIN LAW and LAURENT MILOT
      Cancer Genomics & Proteomics September 2021, 18 (5) 627-635; DOI: https://doi.org/10.21873/cgp.20285

  2. STRATIS, IOANNIS G.

    1. Machine Learning Approaches on High Throughput NGS Data to Unveil Mechanisms of Function in Biology and Disease
      VASILEIOS C. PEZOULAS, ORSALIA HAZAPIS, NEFELI LAGOPATI, THEMIS P. EXARCHOS, ANDREAS V. GOULES, ATHANASIOS G. TZIOUFAS, DIMITRIOS I. FOTIADIS, IOANNIS G. STRATIS, ATHANASIOS N. YANNACOPOULOS and VASSILIS G. GORGOULIS
      Cancer Genomics & Proteomics September 2021, 18 (5) 605-626; DOI: https://doi.org/10.21873/cgp.20284

T

  1. TSUCHIYA, HIROYUKI

    1. Multikinase-Inhibitor Screening in Drug-resistant Osteosarcoma Patient-derived Orthotopic Xenograft Mouse Models Identifies the Clinical Potential of Regorafenib
      TAKASHI HIGUCHI, KENTARO IGARASHI, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, MICHAEL BOUVET, HIROYUKI TSUCHIYA and ROBERT M. HOFFMAN
      Cancer Genomics & Proteomics September 2021, 18 (5) 637-643; DOI: https://doi.org/10.21873/cgp.20286

  2. TZIOUFAS, ATHANASIOS G.

    1. Machine Learning Approaches on High Throughput NGS Data to Unveil Mechanisms of Function in Biology and Disease
      VASILEIOS C. PEZOULAS, ORSALIA HAZAPIS, NEFELI LAGOPATI, THEMIS P. EXARCHOS, ANDREAS V. GOULES, ATHANASIOS G. TZIOUFAS, DIMITRIOS I. FOTIADIS, IOANNIS G. STRATIS, ATHANASIOS N. YANNACOPOULOS and VASSILIS G. GORGOULIS
      Cancer Genomics & Proteomics September 2021, 18 (5) 605-626; DOI: https://doi.org/10.21873/cgp.20284

W

  1. WEIDLE, ULRICH H.

    1. MicroRNAs Involved in Small-cell Lung Cancer as Possible Agents for Treatment and Identification of New Targets
      ULRICH H. WEIDLE and ADAM NOPORA
      Cancer Genomics & Proteomics September 2021, 18 (5) 591-603; DOI: https://doi.org/10.21873/cgp.20283

  2. WOO, SEON RANG

    1. SOD2- and NRF2-associated Gene Signature to Predict Radioresistance in Head and Neck Cancer
      JOO KYUNG NOH, SEON RANG WOO, MIYONG YUN, MIN KYEONG LEE, MOONKYOO KONG, SOONKI MIN, SU IL KIM, YOUNG CHAN LEE, YOUNG-GYU EUN and SEONG-GYU KO
      Cancer Genomics & Proteomics September 2021, 18 (5) 675-684; DOI: https://doi.org/10.21873/cgp.20289

Y

  1. YAMAMOTO, NORIO

    1. Multikinase-Inhibitor Screening in Drug-resistant Osteosarcoma Patient-derived Orthotopic Xenograft Mouse Models Identifies the Clinical Potential of Regorafenib
      TAKASHI HIGUCHI, KENTARO IGARASHI, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, MICHAEL BOUVET, HIROYUKI TSUCHIYA and ROBERT M. HOFFMAN
      Cancer Genomics & Proteomics September 2021, 18 (5) 637-643; DOI: https://doi.org/10.21873/cgp.20286

  2. YANNACOPOULOS, ATHANASIOS N.

    1. Machine Learning Approaches on High Throughput NGS Data to Unveil Mechanisms of Function in Biology and Disease
      VASILEIOS C. PEZOULAS, ORSALIA HAZAPIS, NEFELI LAGOPATI, THEMIS P. EXARCHOS, ANDREAS V. GOULES, ATHANASIOS G. TZIOUFAS, DIMITRIOS I. FOTIADIS, IOANNIS G. STRATIS, ATHANASIOS N. YANNACOPOULOS and VASSILIS G. GORGOULIS
      Cancer Genomics & Proteomics September 2021, 18 (5) 605-626; DOI: https://doi.org/10.21873/cgp.20284

  3. YUN, MIYONG

    1. SOD2- and NRF2-associated Gene Signature to Predict Radioresistance in Head and Neck Cancer
      JOO KYUNG NOH, SEON RANG WOO, MIYONG YUN, MIN KYEONG LEE, MOONKYOO KONG, SOONKI MIN, SU IL KIM, YOUNG CHAN LEE, YOUNG-GYU EUN and SEONG-GYU KO
      Cancer Genomics & Proteomics September 2021, 18 (5) 675-684; DOI: https://doi.org/10.21873/cgp.20289
Back to top

In this issue